Cargando…
Treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy
Drug treatment of Juvenile myoclonic epilepsy (JME) is mainly based on clinical experience and prospective and retrospective studies, with little evidence from randomized clinical trials. There are no head-to-head comparisons between old and new antiepileptic drugs (AEDs) and no drugs licensed speci...
Autor principal: | Auvin, Stéphane |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656314/ https://www.ncbi.nlm.nih.gov/pubmed/19300607 |
Ejemplares similares
-
Juvenile Myoclonic Epilepsy: Seizure and Social Outcomes in Taiwan
por: Lim, Siew-Na, et al.
Publicado: (2023) -
Headache in juvenile myoclonic epilepsy
por: Schankin, Christoph J., et al.
Publicado: (2011) -
Paradoxical exacerbation of myoclonic-astatic seizures by levetiracetam in myoclonic astatic epilepsy
por: Makke, Yamane, et al.
Publicado: (2015) -
Cognitive Impairment in Juvenile Myoclonic Epilepsy
por: Kim, Sun-Young, et al.
Publicado: (2007) -
Insulinoma misdiagnosed as juvenile myoclonic epilepsy
por: Jaladyan, Varsine, et al.
Publicado: (2006)